JP2020517719A5 - - Google Patents

Download PDF

Info

Publication number
JP2020517719A5
JP2020517719A5 JP2019558554A JP2019558554A JP2020517719A5 JP 2020517719 A5 JP2020517719 A5 JP 2020517719A5 JP 2019558554 A JP2019558554 A JP 2019558554A JP 2019558554 A JP2019558554 A JP 2019558554A JP 2020517719 A5 JP2020517719 A5 JP 2020517719A5
Authority
JP
Japan
Prior art keywords
composition
composition according
muscarinic receptor
receptor antagonist
nri
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019558554A
Other languages
English (en)
Japanese (ja)
Other versions
JP7373997B2 (ja
JP2020517719A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/029518 external-priority patent/WO2018200775A1/en
Publication of JP2020517719A publication Critical patent/JP2020517719A/ja
Publication of JP2020517719A5 publication Critical patent/JP2020517719A5/ja
Priority to JP2023108387A priority Critical patent/JP2023139000A/ja
Application granted granted Critical
Publication of JP7373997B2 publication Critical patent/JP7373997B2/ja
Priority to JP2025128090A priority patent/JP2025169279A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019558554A 2017-04-28 2018-04-26 睡眠時無呼吸を治療する方法及び組成物 Active JP7373997B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2023108387A JP2023139000A (ja) 2017-04-28 2023-06-30 睡眠時無呼吸を治療する方法及び組成物
JP2025128090A JP2025169279A (ja) 2017-04-28 2025-07-31 睡眠時無呼吸を治療する方法及び組成物

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762491504P 2017-04-28 2017-04-28
US62/491,504 2017-04-28
US201762558814P 2017-09-14 2017-09-14
US62/558,814 2017-09-14
PCT/US2018/029518 WO2018200775A1 (en) 2017-04-28 2018-04-26 Methods and compositions for treating sleep apnea

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023108387A Division JP2023139000A (ja) 2017-04-28 2023-06-30 睡眠時無呼吸を治療する方法及び組成物

Publications (3)

Publication Number Publication Date
JP2020517719A JP2020517719A (ja) 2020-06-18
JP2020517719A5 true JP2020517719A5 (cg-RX-API-DMAC7.html) 2021-06-10
JP7373997B2 JP7373997B2 (ja) 2023-11-06

Family

ID=63918622

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019558554A Active JP7373997B2 (ja) 2017-04-28 2018-04-26 睡眠時無呼吸を治療する方法及び組成物
JP2023108387A Pending JP2023139000A (ja) 2017-04-28 2023-06-30 睡眠時無呼吸を治療する方法及び組成物
JP2025128090A Pending JP2025169279A (ja) 2017-04-28 2025-07-31 睡眠時無呼吸を治療する方法及び組成物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023108387A Pending JP2023139000A (ja) 2017-04-28 2023-06-30 睡眠時無呼吸を治療する方法及び組成物
JP2025128090A Pending JP2025169279A (ja) 2017-04-28 2025-07-31 睡眠時無呼吸を治療する方法及び組成物

Country Status (21)

Country Link
US (5) US11123313B2 (cg-RX-API-DMAC7.html)
EP (1) EP3615016A4 (cg-RX-API-DMAC7.html)
JP (3) JP7373997B2 (cg-RX-API-DMAC7.html)
KR (3) KR20250145704A (cg-RX-API-DMAC7.html)
CN (2) CN119185558A (cg-RX-API-DMAC7.html)
AU (3) AU2018260666B2 (cg-RX-API-DMAC7.html)
CA (1) CA3061468A1 (cg-RX-API-DMAC7.html)
CO (1) CO2019013180A2 (cg-RX-API-DMAC7.html)
CR (1) CR20190546A (cg-RX-API-DMAC7.html)
DO (1) DOP2019000274A (cg-RX-API-DMAC7.html)
EC (1) ECSP19084058A (cg-RX-API-DMAC7.html)
GE (6) GEAP202416602A (cg-RX-API-DMAC7.html)
MA (1) MA49069A (cg-RX-API-DMAC7.html)
MX (2) MX394941B (cg-RX-API-DMAC7.html)
MY (1) MY200172A (cg-RX-API-DMAC7.html)
NI (1) NI201900110A (cg-RX-API-DMAC7.html)
PH (1) PH12019502427A1 (cg-RX-API-DMAC7.html)
SG (2) SG11201909973UA (cg-RX-API-DMAC7.html)
UA (1) UA127759C2 (cg-RX-API-DMAC7.html)
WO (1) WO2018200775A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201907158B (cg-RX-API-DMAC7.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119185558A (zh) * 2017-04-28 2024-12-27 布里格姆妇女医院 用于治疗睡眠呼吸暂停的方法和组合物
CN111670050A (zh) 2018-01-30 2020-09-15 爱普宁公司(特拉华) 用于治疗睡眠呼吸暂停的方法和组合物
CN108309261B (zh) * 2018-02-11 2020-05-22 西安交通大学 一种猝死预警方法及装置和系统
WO2019245975A1 (en) 2018-06-17 2019-12-26 Axsome Therapeutics, Inc. Compositions for delivery of reboxetine
US20200147093A1 (en) 2018-10-15 2020-05-14 Axsome Therapeutics, Inc. Use of esreboxetine to treat nervous system disorders such as fibromyalgia
US11020402B2 (en) 2018-10-15 2021-06-01 Axsome Therapeutics, Inc. Use of reboxetine to treat narcolepsy
CA3117766A1 (en) * 2018-10-31 2020-05-07 Apnimed, Inc. (Delaware) Methods and compositions for treating sleep apnea
ES3049086T3 (en) * 2019-02-08 2025-12-12 Brigham & Womens Hospital Inc Methods and compositions for treating sleep apnea
US20220362221A1 (en) * 2019-11-04 2022-11-17 Apnimed, Inc. (Delaware) Combination pharmacological interventions for multiple mechanisms of obstructive sleep apnea
US12616702B2 (en) 2019-12-03 2026-05-05 Axsome Therapeutics, Inc. Use of reboxetine to treat narcolepsy
EP4146621A1 (en) 2020-05-05 2023-03-15 Apnimed, Inc. (Delaware) Polymorphic forms of (r)-oxybutynin hydrochloride
CN114159568B (zh) * 2020-09-11 2025-08-01 北京原基华毅生物科技有限公司 Sik抑制剂在制备用于预防和/或治疗睡眠障碍的药物中的应用
RU2757470C1 (ru) * 2020-11-19 2021-10-18 Ренат Рашитович Ахмеров Способ лечения храпа с помощью введения тромбоцитарной аутологичной плазмы
US20240075035A1 (en) * 2021-01-14 2024-03-07 Apnimed, Inc. (Delaware) Methods and compositions for treating sleep apnea
CA3210092A1 (en) * 2021-03-04 2022-09-09 Lawrence G. Miller Combination of reboxetine and a muscarinic receptor antagonist (mra) for use in treating sleep apnea
CN117177741A (zh) * 2021-04-16 2023-12-05 爱普宁公司(特拉华) 用于治疗睡眠呼吸暂停的去甲肾上腺素再摄取抑制剂和大麻素的组合
JP2024523876A (ja) * 2021-06-17 2024-07-02 アプニメッド,インコーポレイテッド(デラウェア) 睡眠時無呼吸を治療するためのノルエピネフリン再取り込み阻害剤
JP2024534173A (ja) * 2021-08-31 2024-09-18 アプニメッド,インコーポレイテッド(デラウェア) 睡眠時無呼吸を治療するための方法及び組成物
CA3259602A1 (en) 2021-12-22 2023-06-29 Bayer Aktiengesellschaft Combination of an .alpha.2-adrenoceptor subtype c (alpha-2c) antagonists with a muscarinic receptor antagonist for the treatment of sleep apnea
MX2024007768A (es) 2021-12-22 2024-07-01 Bayer Ag Combinacion de un antagonista de adrenoreceptor a2 subtipo c (alfa-2c) con un inhibidor de recaptacion de norepinefrina para el tratamiento de apnea del sue?o.
IL313648A (en) * 2021-12-22 2024-08-01 Bayer Ag Combination of a TASK1/3 channel blocker with a norepinephrine reuptake inhibitor for the treatment of sleep apnea
EP4522149A1 (en) * 2022-05-13 2025-03-19 Apnimed, Inc. (Delaware) Methods and compositions for treating sleep apnea
US20260041659A1 (en) * 2024-08-07 2026-02-12 Yogesh Dandiker Topical atomoxetine and oxybutynin for obstructive sleep apnea
US12565478B1 (en) 2025-01-21 2026-03-03 Axsome Therapeutics, Inc. (S)-2-((S)-(2-ethoxyphenoxy)(phenyl)methyl)-4-nitrosomorpholine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
AU767877B2 (en) 1999-05-20 2003-11-27 Sepracor, Inc. Methods for treatment of asthma using S-oxybutynin
WO2001062236A2 (en) * 2000-02-24 2001-08-30 Pharmacia & Upjohn Company New drug combinations comprising a norepinephrine reuptake inhibitor and an antimuscarinic agent
WO2006023703A2 (en) 2004-08-20 2006-03-02 Cypress Bioscience, Inc. Method for treating sleep related breathing disorders
JP2008524332A (ja) * 2004-12-20 2008-07-10 コレジウム ファーマシューティカル, インク. 睡眠傷害のための医薬組成物
CN107007602A (zh) * 2011-01-28 2017-08-04 辉达斯医学研究所 治疗阻塞性睡眠呼吸暂停的方法
CN119185558A (zh) * 2017-04-28 2024-12-27 布里格姆妇女医院 用于治疗睡眠呼吸暂停的方法和组合物
CN111670050A (zh) 2018-01-30 2020-09-15 爱普宁公司(特拉华) 用于治疗睡眠呼吸暂停的方法和组合物

Similar Documents

Publication Publication Date Title
JP2023139000A5 (cg-RX-API-DMAC7.html)
KR20250145704A (ko) 수면 무호흡을 치료하기 위한 방법 및 조성물
JP2009525343A5 (cg-RX-API-DMAC7.html)
EP2422778A1 (en) Titration of tapentadol
JP2006506378A5 (cg-RX-API-DMAC7.html)
TW201628618A (zh) 用於治療巴金森氏症的類鴉片激動劑與類鴉片拮抗劑之組合
JP2008535867A5 (cg-RX-API-DMAC7.html)
RU2007140348A (ru) Способы и композиции для лечения заболеваний цнс
US20160081938A1 (en) Acamprosate formulations, methods of using the same, and combinations comprising the same
SG189395A1 (en) Antitussive compositions comprising memantine
TWI455723B (zh) 納曲酮及安非他酮於治療超重或肥胖病患之用途
JP2009536176A5 (cg-RX-API-DMAC7.html)
JP2011509295A5 (cg-RX-API-DMAC7.html)
JP2022519721A5 (cg-RX-API-DMAC7.html)
Bied et al. A critical appraisal of the selegiline transdermal system for major depressive disorder
CN102805746A (zh) 一种作用于呼吸系统疾病的复方化学药及其制备工艺与应用
AU2017238051B2 (en) Treatment of uremic pruritus
JP2024511091A5 (cg-RX-API-DMAC7.html)
US11207330B2 (en) Mirtazapine for use in medication overuse headache based on tension-type headache
TW201434464A (zh) 藥物
JP2024523876A5 (cg-RX-API-DMAC7.html)
Verma et al. Antihypertensive efficacy of carvedilol and amlodipine in patients of mild to moderate hypertension–a comparative study
JP2025500344A5 (cg-RX-API-DMAC7.html)
JP2024508498A5 (cg-RX-API-DMAC7.html)
WO2011008686A1 (en) Exo-s-mecamylamine method, use, and compound for treatment